Honda to Recall About 1.7 Million Vehicles Due to Steering Issue
Honda is recalling about 1.7 million vehicles because steering-gearbox issues in certain models present a crash hazard, the federal auto-safety regulator said.
Kymera Therapeutics' Application for KT-621 Gets FDA Clearance
Kymera Therapeutics received clearance from the Food and Drug Administration for its investigational new drug application of KT-621. The clinical stage biopharmaceutical company said it expects to ...
How phones and computers are bombarding our brains and creating a FOMO epidemic
But here's the catch: The pleasure we derive from screens is shallow and fleeting, unlike the lasting satisfaction that comes from face-to-face interactions. Steady screen interruptions increase ...
Viking Therapeutics' stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD
Viking Therapeutics Inc.'s stock rose 1.4% in premarket trade Wednesday, after the biotech reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic ...
Wall Street's most bearish firm on stocks says there's a chance of an upswing
For investors looking to play the broadening cyclical recovery ahead of the year-end holiday season, they like what they call U.S. consumer laggards with brand value, which include Tesla (TSLA), ...
Nvidia just made two moves that could push its stock to the next level
New AI model and strategic partnership with Accenture are aggressive and defensive Nvidia has just made two aggressive and defensive moves that its shareholders will appreciate. The company unveiled a ...
Ocugen Says FDA Lifts Clinical Hold on Diabetic Macular Edema Drug
Ocugen said the Food and Drug Administration lifted a clinical hold on its OCU200 investigational treatment for diabetic macular edema, paving the way for Phase 1 trials.
Fed Minutes Awaited; New Zealand Makes Half-Point Rate Cut; India Stands Pat, Shifts Policy Stance
In his postmeeting press conference on Sept. 18, Fed chair Jerome Powell said that the FOMC's jumbo cut wasn't a reflection of officials' fear of a recession. He repeatedly referred to the rate ...
Tesla's 'Robotaxi Day' will show that Elon Musk has the EV maker in the fast lane
Robotaxi Day - the expected introduction of Tesla's Cybercab - was postponed a few months ago, which sent Tesla shares (TSLA) into a freefall at the time. In the past few weeks, the stock has found ...
Why a CPI surprise could trip up the Fed's rate-cutting plans
Traders were pricing in a roughly 87% chance of a 25-basis-point rate cut at the Fed's next decision day on Nov. 7, with the odds of no change hovering near 13%, according to the CME's FedWatch tool ...
Arcadium Lithium Shares Soar on $6.7 Billion Rio Tinto Takeover
Shares of Arcadium Lithium surged after the company agreed to be acquired by Rio Tinto for $6.7 billion. The stock was up 30% at $5.53 in premarket trading.
JPMorgan's strategists are starting to sound less bearish on stocks
The team led by Dubravko Lakos-Bujas say the Fed's easing and China stimulus are reviving hopes for a late-cycle reflation trade When Marko Kolanovic departed JPMorgan last summer, he took with him a ...